These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Differences in Coronavirus disease - 19 vaccination related side effects in patients with ulcerative colitis and Crohn's disease in Japan. Miyazaki H; Watanabe D; Ito Y; Ikeda S; Okamoto N; Tokunaga E; Ku Y; Ooi M; Hoshi N; Kodama Y Indian J Gastroenterol; 2023 Oct; 42(5):701-707. PubMed ID: 37505394 [TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection. Liu B; Stepien S; Qian J; Gidding H; Nicolopoulos K; Amin J; Cheng A; Macartney K Vaccine; 2023 Aug; 41(38):5587-5591. PubMed ID: 37524631 [TBL] [Abstract][Full Text] [Related]
9. Pediatric Hospitalizations and ICU Admissions Due to COVID-19 and Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 in England. Ward JL; Harwood R; Kenny S; Cruz J; Clark M; Davis PJ; Draper ES; Hargreaves D; Ladhani SN; Gent N; Williams HE; Luyt K; Turner S; Whittaker E; Bottle A; Fraser LK; Viner RM JAMA Pediatr; 2023 Jul; 177(9):947-55. PubMed ID: 37523172 [TBL] [Abstract][Full Text] [Related]
10. Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India: A Phase 2-3 Randomized Clinical Trial. Gunale B; Kapse D; Kar S; Bavdekar A; Kohli S; Lalwani S; Meshram S; Raut A; Kulkarni P; Samuel C; Munshi R; Gupta M; Plested JS; Cloney-Clark S; Zhu M; Pryor M; Hamilton S; Thakar M; Shete A; Dharmadhikari A; Bhamare C; Shaligram U; Poonawalla CS; Mallory RM; Glenn GM; Kulkarni PS; JAMA Pediatr; 2023 Jul; 177(9):911-20. PubMed ID: 37523166 [TBL] [Abstract][Full Text] [Related]
11. Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis. Meeraus W; de Munter L; Gray CM; Dwivedi A; Wyndham-Thomas C; Ouwens M; Hartig-Merkel W; Drikite L; Rebry G; Carmona A; Stuurman AL; Chi Nguyen TY; Mena G; Mira-Iglesias A; Icardi G; Otero-Romero S; Baumgartner S; Martin C; Taylor S; Bollaerts K Lancet Reg Health Eur; 2023 Aug; 31():100675. PubMed ID: 37547274 [TBL] [Abstract][Full Text] [Related]
12. A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov. Wang SY; Liu WQ; Li YQ; Li JX; Zhu FC Expert Rev Vaccines; 2023; 22(1):704-713. PubMed ID: 37501516 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccine registry for pregnant women: policy to control complications of vaccination in pregnant women in 2021-2022. Asadi F; Shakiba R; Rabiei R; Emami H; Sabahi A BMC Pregnancy Childbirth; 2023 Jul; 23(1):542. PubMed ID: 37501112 [TBL] [Abstract][Full Text] [Related]
14. Dimensional structure of one-year post-COVID-19 neuropsychiatric and somatic sequelae and association with role impairment. Leung ONW; Chiu NKH; Wong SYS; Cuijpers P; Alonso J; Chan PKS; Lui G; Wong E; Bruffaerts R; Yip BHK; Mortier P; Vilagut G; Kwok D; Lam LCW; Kessler RC; Mak ADP Sci Rep; 2023 Jul; 13(1):12205. PubMed ID: 37500708 [TBL] [Abstract][Full Text] [Related]
15. Adverse effect of VEGFR-2 (rs1870377) polymorphism on the clinical course of COVID-19 in females and males in an age-dependent manner. Sayın Kocakap DB; Kaygusuz S; Aksoy E; Şahin Ö; Baççıoğlu A; Ekici A; Kalpaklıoğlu AF; Ekici MS; Gül S; Kaçmaz B; Ayaşlıoğlu Açıkgöz E; Alyılmaz Bekmez S; Rouse BT; Azkur AK Microbes Infect; 2023; 25(8):105188. PubMed ID: 37499788 [TBL] [Abstract][Full Text] [Related]
16. Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine. Guo S; Zheng Y; Gao Z; Duan M; Liu S; Du P; Xu X; Xu K; Zhao X; Chai Y; Wang P; Zhao Q; Gao GF; Dai L Cell Discov; 2023 Jul; 9(1):79. PubMed ID: 37507370 [TBL] [Abstract][Full Text] [Related]
17. Proteolytic inactivation of CXCL12 in the lungs and circulation of COVID-19 patients. Cambier S; Beretta F; Pörtner N; Metzemaekers M; de Carvalho AC; Martens E; Kaes J; Aelbrecht C; Jacobs C; Van Mol P; Wauters E; Meersseman P; Hermans G; Marques RE; Vanaudenaerde B; Vos R; Wauters J; Gouwy M; Proost P Cell Mol Life Sci; 2023 Jul; 80(8):234. PubMed ID: 37505242 [TBL] [Abstract][Full Text] [Related]
18. The worldwide COVID-19 lockdown impacts on global secondary inorganic aerosols and radiative budget. Sekiya T; Miyazaki K; Eskes H; Bowman K; Sudo K; Kanaya Y; Takigawa M Sci Adv; 2023 Jul; 9(30):eadh2688. PubMed ID: 37506199 [TBL] [Abstract][Full Text] [Related]
19. Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses. Kalanaky S; Fakharzadeh S; Karimi P; Hafizi M; Jamaati H; Hassanzadeh SM; Khorasani A; Mahdavi M; Nazaran MH Viral Immunol; 2023; 36(6):409-423. PubMed ID: 37506342 [TBL] [Abstract][Full Text] [Related]
20. Where are the long COVID trials? The Lancet Infectious Diseases Lancet Infect Dis; 2023 Aug; 23(8):879. PubMed ID: 37507151 [No Abstract] [Full Text] [Related] [Next] [New Search]